Stock ELVN ENLIVEN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Enliven Therapeutics, Inc.

Equities

ELVN

US29337E1029

Delayed Nasdaq
Other stock markets
 03:48:57 2024-05-29 pm EDT 		5-day change 1st Jan Change
21.22 USD -8.61% Intraday chart for Enliven Therapeutics, Inc. -7.30% +53.32%
May. 20 Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing MT
May. 14 Enliven Therapeutics Q1 Loss Narrows MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Enliven Therapeutics Insider Sold Shares Worth $22,877,262, According to a Recent SEC Filing
MT
Enliven Therapeutics, Inc. Appoints Lori Kunkel to Board of Directors
CI
Enliven Therapeutics Insider Sold Shares Worth $104,999, According to a Recent SEC Filing
MT
Enliven Therapeutics Insider Sold Shares Worth $111,751, According to a Recent SEC Filing
MT
Enliven Therapeutics Insider Sold Shares Worth $163,498, According to a Recent SEC Filing
MT
Enliven Therapeutics, Inc. Announces CEO Changes
CI
Enliven Therapeutics, Inc. Announces Management Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELVN Stock
  4. News Enliven Therapeutics, Inc.
  5. Insiders